About 14 percent of older adults hospitalized for common, non-cardiac conditions were discharged with more intensive blood pressure medication, according to an analysis published in The BMJ. The concerning part: More than half of those patients actually demonstrated good blood pressure (BP) control in an outpatient setting, suggesting overtreatment from hospital physicians.
Extensive exposure to air pollutants like nitrogen dioxide and fine particulate matter could feed the development of type 2 diabetes (T2D), Chinese researchers reported in a meta-analysis published this month in the European Journal of Endocrinology.
Digital games developed for cardiovascular disease self-management improve exercise capacity and energy expenditure among their users, according to a review published Sept. 18 in the Games for Health Journal, but the approach does little to overcome mental hurdles like depression, anxiety and quality of life.
The prevalence of acute myocardial infarction (AMI) in the heart transplant (HT) population is “very low,” according to research published in the current online edition of the American Journal of Cardiology, but HT patients who do suffer a heart attack are more likely to experience longer hospital stays, higher 30-day readmission rates and greater in-hospital morbidities.
A Journal of the American College of Cardiology study this week linked long-term alcohol consumption to adverse cardiac remodeling in patients who were initially young and healthy—something the paper’s authors said might be offset by drinking predominantly wine.
Half of patients who receive percutaneous coronary intervention (PCI) at Veterans Affairs (VA) hospitals in the U.S. travel more than 48 miles for the procedure; a quarter travel at least 110 miles. Yet distance to the PCI site doesn’t significantly influence one-year outcomes, a recent study found.
The FDA has approved Contego Medical’s Paladain Carotid PTA Balloon System, the first approved embolic protection device to contain both a carotid angioplasty balloon and an integrated filter.
DUBLIN — September 18, 2018 — Medtronic plc (NYSE:MDT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a single-arm study to evaluate the CoreValve Evolut(TM)TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality.
FLAGSTAFF, Ariz. (SEPTEMBER 17, 2018) — W. L. Gore & Associates, Inc. (Gore) today announced the first European patient implant of the GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System. This next-generation endovascular aneurysm repair (EVAR) device is indicated to treat the broadest range of abdominal aortic aneurysms (AAA) in patients with challenging anatomies.
ST-segment elevation myocardial infarction (STEMI) patients have better odds of survival if emergency medical services (EMS) personnel alert the hospital where the patient will be arriving ahead of time, according to a study published Sept. 17 in JACC: Cardiovascular Interventions.
